These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions. Mikuls TR; Duryee MJ; England BR; Anderson DR; Hearth-Holmes M; Su K; Michaud K; Payne JB; Sayles H; Hunter C; McGowan JD; Klassen LW; Thiele GM Int Immunopharmacol; 2018 Mar; 56():113-118. PubMed ID: 29414640 [TBL] [Abstract][Full Text] [Related]
6. Associations between periodontitis and serum anti-malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis: A case-control study. Lee JA; Mikuls TR; Sayles HR; Thiele GM; Duryee MJ; Payne JB J Periodontol; 2024 Oct; 95(10):929-941. PubMed ID: 38728106 [TBL] [Abstract][Full Text] [Related]
7. Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts. Thiele GM; Duryee MJ; Hunter CD; England BR; Fletcher BS; Daubach EC; Pospisil TP; Klassen LW; Mikuls TR Int Immunopharmacol; 2020 Jun; 83():106433. PubMed ID: 32224441 [TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis. Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L Front Immunol; 2021; 12():627986. PubMed ID: 34093522 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis. Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967 [TBL] [Abstract][Full Text] [Related]
11. Antibodies to Malondialdehyde-Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease in US Veterans. Aripova N; Thiele GM; Duryee MJ; Hunter CD; Yang Y; Roul P; Ascherman DP; Matson SM; Kunkel G; Cannon GW; Wysham KD; Kerr GS; Monach PA; Baker JF; Poole JA; Mikuls TR; England BR Arthritis Rheumatol; 2024 Sep; 76(9):1353-1363. PubMed ID: 38766737 [TBL] [Abstract][Full Text] [Related]
12. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412 [TBL] [Abstract][Full Text] [Related]
13. Autoreactive B cells against malondialdehyde-induced protein cross-links are present in the joint, lung, and bone marrow of rheumatoid arthritis patients. Sahlström P; Joshua V; Valkovskaia V; Biese C; Stålesen R; Israelsson L; Végvári Á; Scheel-Toellner D; Klareskog L; Hansson M; Hensvold A; Malmström V; Grönwall C J Biol Chem; 2023 Nov; 299(11):105320. PubMed ID: 37802315 [TBL] [Abstract][Full Text] [Related]
14. What is the ability of anti-cyclic citrullinated peptide antibodies determination in synovial fluid in discriminating rheumatoid arthritis from non-rheumatoid arthritis patients? A Tunisian cross-sectional study. Mrabet D; Laadhar L; Sahli H; Zouari B; Haouet S; Lahmar H; Makni S; Sellami S Clin Rheumatol; 2012 Feb; 31(2):375-9. PubMed ID: 21952975 [TBL] [Abstract][Full Text] [Related]
15. Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage. Glant TT; Ocsko T; Markovics A; Szekanecz Z; Katz RS; Rauch TA; Mikecz K PLoS One; 2016; 11(3):e0150784. PubMed ID: 26943656 [TBL] [Abstract][Full Text] [Related]
16. B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status. Michelutti A; Gremese E; Morassi F; Petricca L; Arena V; Tolusso B; Alivernini S; Peluso G; Bosello SL; Ferraccioli G Mol Med; 2011; 17(9-10):901-9. PubMed ID: 21607290 [TBL] [Abstract][Full Text] [Related]
17. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis. Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390 [TBL] [Abstract][Full Text] [Related]
18. Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis. Alunno A; Caneparo V; Bistoni O; Caterbi S; Terenzi R; Gariglio M; Bartoloni E; Manzo A; Landolfo S; Gerli R Arthritis Care Res (Hoboken); 2016 Apr; 68(4):440-5. PubMed ID: 26316393 [TBL] [Abstract][Full Text] [Related]
19. Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association. van den Beukel MD; van Wesemael TJ; Hoogslag ATW; Borggreven NV; Huizinga TW; van der Helm-van Mil AH; Toes RE; van der Woude D; Trouw LA RMD Open; 2023 Dec; 9(4):. PubMed ID: 38053459 [TBL] [Abstract][Full Text] [Related]